Inovalon (INOV) Stock Price, News & Analysis

Company Overview

Inovalon Holdings, Inc. engages in the development of cloud-based platforms for the healthcare industry. Its products include datasets, integration technologies, predictive analytics, and related services. The company was founded in 1998 and is headquartered in Bowie, MD.

Key Stats

• Today's Range: $30.03 to $30.07
• 50-Day Range: $40.66 to $41.06
• 52-Week Range: $17.56 to $41.06
• Volume: 8,970 shs
• Average Volume: 720,587 shs
• Market Capitalization: $4.66 billion
• P/E Ratio: 88.33
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

INOV Stock Analysis - Frequently Asked Questions

How were Inovalon's earnings last quarter?

Inovalon Holdings, Inc. (NASDAQ:INOV) released its quarterly earnings data on Wednesday, July, 28th. The technology company reported $0.19 earnings per share for the quarter, beating the consensus estimate of $0.17 by $0.02. The technology company had revenue of $190.44 million for the quarter, compared to the consensus estimate of $183.89 million. Inovalon had a trailing twelve-month return on equity of 10.97% and a net margin of 6.73%.

When did Inovalon IPO?

Inovalon (INOV) raised $500 million in an initial public offering (IPO) on Thursday, February 12th 2015. The company issued 22,200,000 shares at a price of $21.00-$24.00 per share. Goldman Sachs, Morgan Stanley, Citigroup, BofA Merrill Lynch and UBS Investment Bank acted as the underwriters for the IPO and Baird, Piper Jaffray, Wells Fargo Securities and William Blair were co-managers.

Who are Inovalon's major shareholders?

Inovalon's top institutional investors include Raymond James Financial Inc. (0.06%), Raymond James Financial Inc. (0.06%), WPWealth LLP (0.04%) and Citadel Advisors LLC (0.01%).
View institutional ownership trends.

What other stocks do shareholders of Inovalon own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Inovalon investors own include NVIDIA (NVDA), Pfizer (PFE), Advanced Micro Devices (AMD), Moderna (MRNA), Meta Platforms (META) and PayPal (PYPL).

Company Calendar

• Last Earnings: 7/28/2021
• Today: 2/22/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Computer and Technology
• Industry: Data Processing & Preparation
• Sub-Industry: N/A
• Current Symbol: NASDAQ:INOV
• CUSIP: N/A
• CIK: 1619954
• Web: www.inovalon.com
• Phone: (301) 809-4000
• Fax: 301-809-8060
• Employees: 1,836
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): $0.34
• Trailing P/E Ratio: 88.33
• Forward P/E Ratio: 50.05
• P/E Growth: 2.99
• Net Income: $22.58 million
• Net Margins: 6.73%
• Pretax Margin: 5.86%
• Return on Equity: 10.97%
• Return on Assets: 4.10%

Debt

• Debt-to-Equity Ratio: 1.17
• Current Ratio: 2.40
• Quick Ratio: 2.40

Sales & Book Value

• Annual Sales: $667.52 million
• Price / Sales: 6.98
• Cash Flow: $0.90 per share
• Price / Cash Flow: 33.35
• Book Value: $4.94 per share
• Price / Book: 6.08

Miscellaneous

• Outstanding Shares: 155,246,000
• Free Float: 78,011,000
• Market Cap: $4.66 billion
• Optionable: No Data
• Beta: 0.53